These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 35453346)

  • 1. BRD4 Targets the KEAP1-Nrf2-G6PD Axis and Suppresses Redox Metabolism in Small Cell Lung Cancer.
    Lv Y; Lv X; Zhang J; Cao G; Xu C; Zhang B; Lin W
    Antioxidants (Basel); 2022 Mar; 11(4):. PubMed ID: 35453346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The bromodomain protein BRD4 regulates the KEAP1/NRF2-dependent oxidative stress response.
    Hussong M; Börno ST; Kerick M; Wunderlich A; Franz A; Sültmann H; Timmermann B; Lehrach H; Hirsch-Kauffmann M; Schweiger MR
    Cell Death Dis; 2014 Apr; 5(4):e1195. PubMed ID: 24763052
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BRD4 contributes to high-glucose-induced podocyte injury by modulating Keap1/Nrf2/ARE signaling.
    Zuo H; Wang S; Feng J; Liu X
    Biochimie; 2019 Oct; 165():100-107. PubMed ID: 31325480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-146b-5p protects oligodendrocyte precursor cells from oxygen/glucose deprivation-induced injury through regulating Keap1/Nrf2 signaling via targeting bromodomain-containing protein 4.
    Li X; Zhang W; Xiao M; Wang F; Zhou P; Yang J; Chen X
    Biochem Biophys Res Commun; 2019 Jun; 513(4):875-882. PubMed ID: 31003769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suppression of bromodomain-containing protein 4 protects trophoblast cells from oxidative stress injury by enhancing Nrf2 activation.
    Wu Y; Mi Y; Zhang F; Cheng Y; Wu X
    Hum Exp Toxicol; 2021 May; 40(5):742-753. PubMed ID: 33094643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LKB1 and KEAP1/NRF2 Pathways Cooperatively Promote Metabolic Reprogramming with Enhanced Glutamine Dependence in
    Galan-Cobo A; Sitthideatphaiboon P; Qu X; Poteete A; Pisegna MA; Tong P; Chen PH; Boroughs LK; Rodriguez MLM; Zhang W; Parlati F; Wang J; Gandhi V; Skoulidis F; DeBerardinis RJ; Minna JD; Heymach JV
    Cancer Res; 2019 Jul; 79(13):3251-3267. PubMed ID: 31040157
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergy between the KEAP1/NRF2 and PI3K Pathways Drives Non-Small-Cell Lung Cancer with an Altered Immune Microenvironment.
    Best SA; De Souza DP; Kersbergen A; Policheni AN; Dayalan S; Tull D; Rathi V; Gray DH; Ritchie ME; McConville MJ; Sutherland KD
    Cell Metab; 2018 Apr; 27(4):935-943.e4. PubMed ID: 29526543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dysfunctional KEAP1-NRF2 interaction in non-small-cell lung cancer.
    Singh A; Misra V; Thimmulappa RK; Lee H; Ames S; Hoque MO; Herman JG; Baylin SB; Sidransky D; Gabrielson E; Brock MV; Biswal S
    PLoS Med; 2006 Oct; 3(10):e420. PubMed ID: 17020408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Keap1-Nrf2 Interaction Suppresses Cell Motility in Lung Adenocarcinomas by Targeting the S100P Protein.
    Chien MH; Lee WJ; Hsieh FK; Li CF; Cheng TY; Wang MY; Chen JS; Chow JM; Jan YH; Hsiao M; Hua KT; Kuo ML
    Clin Cancer Res; 2015 Oct; 21(20):4719-32. PubMed ID: 26078391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The discovery and characterization of K-563, a novel inhibitor of the Keap1/Nrf2 pathway produced by Streptomyces sp.
    Hori R; Yamaguchi K; Sato H; Watanabe M; Tsutsumi K; Iwamoto S; Abe M; Onodera H; Nakamura S; Nakai R
    Cancer Med; 2019 Mar; 8(3):1157-1168. PubMed ID: 30735010
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene-expression signature regulated by the KEAP1-NRF2-CUL3 axis is associated with a poor prognosis in head and neck squamous cell cancer.
    Namani A; Matiur Rahaman M; Chen M; Tang X
    BMC Cancer; 2018 Jan; 18(1):46. PubMed ID: 29306329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic Therapeutics Targeting NRF2/KEAP1 Signaling in Cancer Oxidative Stress.
    Zhang S; Duan S; Xie Z; Bao W; Xu B; Yang W; Zhou L
    Front Pharmacol; 2022; 13():924817. PubMed ID: 35754474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucose availability is a decisive factor for Nrf2-mediated gene expression.
    Heiss EH; Schachner D; Zimmermann K; Dirsch VM
    Redox Biol; 2013; 1(1):359-65. PubMed ID: 24024172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting the cell signaling pathway Keap1-Nrf2 as a therapeutic strategy for adenocarcinomas of the lung.
    Zhang B; Ma Z; Tan B; Lin N
    Expert Opin Ther Targets; 2019 Mar; 23(3):241-250. PubMed ID: 30556750
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting BRD4 proteins suppresses the growth of NSCLC through downregulation of eIF4E expression.
    Gao Z; Yuan T; Zhou X; Ni P; Sun G; Li P; Cheng Z; Wang X
    Cancer Biol Ther; 2018 May; 19(5):407-415. PubMed ID: 29333921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of deficiency of Kelch-like ECH-associated protein 1 on skeletal organization: a mechanism for diminished nuclear factor of activated T cells cytoplasmic 1 during osteoclastogenesis.
    Sakai E; Morita M; Ohuchi M; Kido MA; Fukuma Y; Nishishita K; Okamoto K; Itoh K; Yamamoto M; Tsukuba T
    FASEB J; 2017 Sep; 31(9):4011-4022. PubMed ID: 28515152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. KEAP1/NRF2 (NFE2L2) mutations in NSCLC - Fuel for a superresistant phenotype?
    Dempke WCM; Reck M
    Lung Cancer; 2021 Sep; 159():10-17. PubMed ID: 34303275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of the NRF2 antioxidant program sensitizes tumors to G6PD inhibition.
    Ding H; Chen Z; Wu K; Huang SM; Wu WL; LeBoeuf SE; Pillai RG; Rabinowitz JD; Papagiannakopoulos T
    Sci Adv; 2021 Nov; 7(47):eabk1023. PubMed ID: 34788087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatocyte-specific NRF2 activation controls fibrogenesis and carcinogenesis in steatohepatitis.
    Mohs A; Otto T; Schneider KM; Peltzer M; Boekschoten M; Holland CH; Hudert CA; Kalveram L; Wiegand S; Saez-Rodriguez J; Longerich T; Hengstler JG; Trautwein C
    J Hepatol; 2021 Mar; 74(3):638-648. PubMed ID: 33342543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fuzzy complex formation between the intrinsically disordered prothymosin α and the Kelch domain of Keap1 involved in the oxidative stress response.
    Khan H; Cino EA; Brickenden A; Fan J; Yang D; Choy WY
    J Mol Biol; 2013 Mar; 425(6):1011-27. PubMed ID: 23318954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.